Physician profile

Edward E Hernaez

Family Medicine · Niles, IL

NPI 1417001108

$839.80

in general payments reported to CMS, 2019-2025

12 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$468.93

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Amgen INC. $327.50 2024 Krystexxa
Horizon Therapeutics Plc $110.53 2019
Inspire Medical Systems, INC. $97.48 2023 Inspire
Sanofi Pasteur INC. $47.80 2019-2022
Kaleo, INC. $47.65 2019
Pfizer INC. $43.95 2023
Takeda Pharmaceuticals U.S.A., INC. $38.93 2021
Sanofi-Aventis U.S. LLC $32.42 2019
Cranial Technologies, INC $29.01 2019
Phadia US INC. $23.75 2021
Astrazeneca Pharmaceuticals LP $23.14 2019
Shire North American Group INC $17.64 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Edward E Hernaez

$839.80

in general payments reported 2019-2025

Years
2019-2024
Top company
Amgen INC.

https://glasscript.com/doctor/18990/edward-e-hernaez

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.